Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial

NCT04400799 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT04400799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04400799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial
Lead sponsor
University of Zurich
Phase
Phase 3
Overall status
Terminated
Start date
June 15, 2020
Completion date
April 12, 2022
Enrollment
475 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, pulmonary embolism, deep vein thrombosis